The Pacific Northwest is redefining what’s possible at the intersection of AI and drug discovery, and Washington state is leading the charge.
Pacific Northwest National Laboratory (PNNL) campus in Richland, WA is playing a key role in the Genesis Mission, helping integrate AI workflows to improve experiments and accelerate biological research.
“PNNL’s leadership in the Department of Energy’s Genesis Mission reinforces the state’s reputation for transforming complex science into real-world impact, elevating the region’s visibility in life sciences and beyond,” Marc Cummings, president and CEO, Life Science Washington, tells PharmaCircle.
Meanwhile, Seattle is quickly positioning itself as the Silicon Valley of AI Life Sciences, with startups and initiatives bolstering the region’s reputation. Proteins, cell and gene therapies, and antibodies are among the top five molecule types that VCs are funding in the Emerald City.
Additional mentions of Synthesize Bio, Xaira Therapeutics, and Pauling.AI highlight how this innovation is taking shape across the region.
Washington has the talent, infrastructure, research institutions, and investment community to further cement its position as a global leader in AI-powered medicine.